Thompson Siegel & Walmsley LLC Sells 279,655 Shares of The Allstate Co. (NYSE:ALL)

Thompson Siegel & Walmsley LLC decreased its position in The Allstate Co. (NYSE:ALL - Free Report) by 41.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 400,116 shares of the insurance provider's stock after selling 279,655 shares during the quarter. Thompson Siegel & Walmsley LLC owned 0.15% of Allstate worth $56,008,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ALL. Ellsworth Advisors LLC purchased a new position in Allstate in the 4th quarter valued at $4,312,000. SteelPeak Wealth LLC lifted its holdings in Allstate by 175.2% in the 4th quarter. SteelPeak Wealth LLC now owns 15,682 shares of the insurance provider's stock valued at $2,209,000 after purchasing an additional 9,984 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in Allstate by 484.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 332,104 shares of the insurance provider's stock valued at $46,488,000 after purchasing an additional 275,319 shares in the last quarter. Meeder Asset Management Inc. increased its stake in shares of Allstate by 214.6% during the 4th quarter. Meeder Asset Management Inc. now owns 1,570 shares of the insurance provider's stock valued at $220,000 after acquiring an additional 1,071 shares during the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its stake in shares of Allstate by 88.7% during the 4th quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 24,496 shares of the insurance provider's stock valued at $3,429,000 after acquiring an additional 11,512 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Allstate Price Performance

Shares of ALL traded up $1.25 during mid-day trading on Friday, hitting $172.71. The company's stock had a trading volume of 901,037 shares, compared to its average volume of 1,563,450. The Allstate Co. has a fifty-two week low of $100.57 and a fifty-two week high of $177.37. The stock has a market capitalization of $45.58 billion, a price-to-earnings ratio of 38.13, a PEG ratio of 0.38 and a beta of 0.51. The firm has a 50-day moving average price of $167.23 and a 200 day moving average price of $152.53. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The insurance provider reported $5.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.11 by $1.02. Allstate had a net margin of 2.31% and a return on equity of 14.44%. The firm had revenue of $15.26 billion for the quarter, compared to analyst estimates of $12.76 billion. During the same quarter in the previous year, the business posted ($1.30) earnings per share. The firm's quarterly revenue was up 10.7% compared to the same quarter last year. On average, research analysts predict that The Allstate Co. will post 14.99 EPS for the current fiscal year.

Allstate Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Monday, March 4th were given a dividend of $0.92 per share. The ex-dividend date of this dividend was Friday, March 1st. This is a positive change from Allstate's previous quarterly dividend of $0.89. This represents a $3.68 dividend on an annualized basis and a dividend yield of 2.13%. Allstate's payout ratio is 81.24%.

Insider Activity at Allstate

In other news, insider John E. Dugenske sold 31,000 shares of Allstate stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total value of $5,276,200.00. Following the transaction, the insider now directly owns 63,731 shares of the company's stock, valued at $10,847,016.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Allstate news, insider John E. Dugenske sold 31,000 shares of the business's stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the sale, the insider now directly owns 63,731 shares of the company's stock, valued at approximately $10,847,016.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of the business's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total transaction of $637,880.00. Following the sale, the chief accounting officer now directly owns 10,736 shares in the company, valued at $1,712,069.92. The disclosure for this sale can be found here. 1.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ALL has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their target price on shares of Allstate from $185.00 to $193.00 and gave the stock an "overweight" rating in a research report on Thursday, May 2nd. HSBC upgraded Allstate from a "hold" rating to a "buy" rating and increased their target price for the company from $158.00 to $190.00 in a research note on Thursday, March 28th. Piper Sandler increased their target price on Allstate from $172.00 to $188.00 and gave the company an "overweight" rating in a research note on Monday, April 1st. Keefe, Bruyette & Woods raised their price objective on Allstate from $181.00 to $189.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 10th. Finally, BMO Capital Markets raised their target price on Allstate from $140.00 to $158.00 and gave the company a "market perform" rating in a research note on Friday, January 19th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $174.59.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.